Accessibility Menu
Hc Surgical Specialists logo

Hc Surgical Specialists(SGX) 1B1

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
$0.00
+0.00%
+0.00Today

Hc Surgical Specialists Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SGD 19.14M

Net Income (TTM)

SGD 9.03M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Jul 28, 2025

1B1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hc Surgical Specialists

HC Surgical Specialists Limited is a Singapore-based investment holding company that specializes in a wide range of medical services. The company focuses on endoscopic procedures and general surgical services, particularly in colorectal health, while also offering orthopedic and home care services.

Products and Services
  • Endoscopic procedures including gastroscopies and colonoscopies
  • General surgical services for various conditions
  • Comprehensive home care services including nursing and therapy
Growth Outlook
  • Revenue of SGD 4.89 million in Q2 2025, consistent with previous quarters
  • Net income margin of 40.6% in Q2 2025, indicating strong profitability
  • Return on equity of 40.98% TTM, showcasing effective capital utilization
Financial Highlights
  • TTM revenue of SGD 19.5 million, reflecting steady growth
  • Dividend yield of 6.30%, attractive for income-focused investors
  • Operating income margin of 44.71% TTM, demonstrating operational efficiency
HC Surgical Specialists Limited has established itself as a key player in the healthcare sector in Singapore, focusing on advanced medical procedures and comprehensive care. The company's commitment to quality and innovation is evident in its diverse offerings, which cater to a wide range of patient needs. Recent financial performance indicates a solid revenue stream and strong profitability, making it an appealing option for potential investors interested in the healthcare industry. The company's strategic focus on endoscopic and surgical services, combined with its community health initiatives, positions it well for future growth in a rapidly evolving market.
AI Generated • Aug 11, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Sieu Min Heah, MD

Website

www.hcsurgicalspecialists.com

Headquarters

Singapore, CE 238291, SG

1B1 Financials

Key Financial Metrics (TTM)

Gross Margin

44.47%

Operating Margin

44.34%

Net Income Margin

44.96%

Return on Equity

29.03%

Return on Capital

19.48%

Return on Assets

22.47%

Earnings Yield

N/A

Dividend Yield

6.12%

Payout Ratio

37.31%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

SGD 8.47M

Operating Income

SGD 8.45M

EBITDA

SGD 5.35M

Operating Cash Flow

SGD 7.42M

Capital Expenditure

-SGD 475.00K

Free Cash Flow

SGD 6.95M

Cash & ST Invst.

SGD 6.96M

Total Debt

SGD 2.40M

Hc Surgical Specialists Performance Analysis

Hc Surgical Specialists annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-05-31SGD 19,077,000-1.2%
20242024-05-31SGD 18,810,000-1.4%
20252025-05-31SGD 19,108,0001.6%
20262026-05-31SGD 19,380,0001.4%
Hc Surgical Specialists sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-02-28-5.9%
Q42025-05-31N/A
Q12025-08-314.5%
Q22025-11-30N/A
Hc Surgical Specialists annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-05-31SGD 0.02-54.2%
20242024-05-31SGD 0.0329.1%
20252025-05-31SGD 0.05117.0%
20262026-05-31SGD 0.05-17.1%
Hc Surgical Specialists sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-02-2850.0%
Q42025-05-31N/A
Q12025-08-31-21.8%
Q22025-11-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

SGD 4.89M

-1.6%

Gross Profit

SGD 2.19M

-9.3%

Gross Margin

44.85%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

18

N/A

Net Income

SGD 1.99M

+17.5%

EBITDA

SGD 1.40M

-15.6%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

SGD 6.96M

+49.2%

Total Debt

SGD 2.40M

-40.9%

Accounts Receivable

SGD 1.76M

-21.1%

Inventory

SGD 380.00K

+0.3%

Long Term Debt

SGD 1.07M

-43.8%

Short Term Debt

SGD 1.33M

-38.3%

Return on Assets

22.47%

N/A

Return on Invested Capital

26.56%

N/A

Free Cash Flow

SGD 1.72M

+6.3%

Operating Cash Flow

SGD 1.73M

+5.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 1B1

What is the current price of Hc Surgical Specialists?

Hc Surgical Specialists is trading at N/A per share.

What is the 52-week range for Hc Surgical Specialists?

Over the past 52 weeks, Hc Surgical Specialists has traded between N/A and N/A.

How much debt does Hc Surgical Specialists have?

As of the most recent reporting period, Hc Surgical Specialists reported total debt of SGD 2.70M.

How much cash does Hc Surgical Specialists have on hand?

Hc Surgical Specialists reported SGD 7.78M in cash and cash equivalents in its most recent financial results.

What is Hc Surgical Specialists’s dividend yield?

Hc Surgical Specialists does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services